OncoVI 2026 publication configuration: facets.method_types
Facets: method types of OncoVI 2026 publication configuration
["conventional_pipeline"]
Correct the method type from none to conventional_pipeline (use-case baseline review 2026-10-12, table 2).
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
7 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Claimed field facets.method_types Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Previous value absent Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Source location OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed value ["conventional_pipeline"] Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Description Correct the method type from none to conventional_pipeline (use-case baseline review 2026-10-12, table 2). Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: subject uc-clinical-20260930-oncovi-study Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Name OncoVI 2026 publication configuration: facets.method_types Context-only references | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP Version: 2026 final full text in Europe PMC XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-02-a7f03c9e55a5 · Record review: source checked
1 source record and release history
- Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Original source · 2026 final full text in Europe PMC XML
Technical metadata and extraction receipts
Stable ID: metadata-correction-tags-20261012-a9026b69570b068ac543
- field
- facets.method_types
- previous value
- absent
- value
- ["conventional_pipeline"]
- source locator
- OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP
- review
- method: source-hash-verification; automated-source-review; reviewer: claude; reviewer note: Separate Claude review agent, independent of the agent that prepared the corrections; no human review claimed; date: 2026-10-12; method note: Compared previous_value with origin/main and the store; re-retrieved the source (live PMC HTML; differs from the source record, as expected for a dynamic page) and read the passage in source_locator; checked the new value against the method-type definitions in data/vocab/method-type.ttl.; artifact sha256: 69ac0b1ef3902b1cb6461c87117db1af4b2035e6a84ab602b0c1d02fc898d28d; retrieval url: https://pmc.ncbi.nlm.nih.gov/articles/PMC13269341/; note: Correct the method type from none to conventional_pipeline (use-case baseline review 2026-10-12, table 2). Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. See docs/reviews/2026-10-12-method-type-corrections.md.